Evidence map›Paper›PMID 32224294›Full record

GuidelineProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie2020

[Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19].

A Méjean, M Rouprêt, F Rozet, K Bensalah, T Murez, X Game, X Rebillard, R Mallet, A Faix, P Mongiat-Artus and 3 more

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.International braz j urol : official journal of the Brazilian Society of Urology · 2020
    Review
  17. Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era.International braz j urol : official journal of the Brazilian Society of Urology · 2020
    Review
  18. Article
  19. Summary and considerations in genitourinary cancer patient care during the COVID-19 Pandemic.International braz j urol : official journal of the Brazilian Society of Urology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

A MéjeanComité de cancérologie de l'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
M RouprêtComité de cancérologie de l'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
F RozetComité de cancérologie de l'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
K BensalahComité de cancérologie de l'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
T MurezComité de cancérologie de l'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
X GameBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
X RebillardBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
R MalletBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
A FaixBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
P Mongiat-ArtusBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
G FournierBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France.
Y NeuzilletBureau du Conseil d'administration d'Association française d'urologie, 11, rue Viète, 75017 Paris, France. Electronic address: yneuzillet@afu.fr.
le comité de cancérologie de l’Association française d’urologie (CCAFU)
Lymphoma Study Association · FRAssociation Française de Chirurgie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe French population is facing the COVID-19 pandemic and the health system have been reoriented in emergency for the care of patients with coronavirus. The management of cancers of the urinary and male genital tracts must be adapted to this context. MATERIAL AND

methodAn expert opinion documented by a literature review was formulated by the Cancerology Committee of the French Association of Urology (CCAFU).

resultsThe medical and surgical management of patients with any cancers of the urinary and male genital tracts must be adapted by modifying the consultation methods, by prioritizing interventions according to the intrinsic prognosis of cancers, taking into account the patient's comorbidities. The protection of urologists from COVID-19 must be considered.

conclusionThe CCAFU issues an expert opinion on the measure to be taken to adapt the management of cancers of the male urinary and genital tract to the context of pandemic by COVID-19.

Indexed as

Coronavirus InfectionsDisease ManagementInfection ControlPandemicsPneumonia, ViralBetacoronavirusCOVID-19Decision MakingEpidemicsHumansInfectious Disease Transmission, Patient-to-ProfessionalMaleSARS-CoV-2Societies, MedicalUrogenital NeoplasmsUrologistsBladder cancerCancer de la prostateCancer de la vessieCancer du penisCancer du reinCancer du testiculeCOVID-19Kidney cancerPenile cancerProstate cancerTesticular cancer

Identifiers

PMID32224294
PMCPMC7146722
OpenAlexW3046339472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.